We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
The development of inducible pluripotent stem [iPS] cells is terribly exciting. Generally, veterinary science has been helpful, barring one anomaly that is that no one got intracytoplasmic sperm injection (ICSI) to work in animals. In horses ICSI is extremely difficult. ICSI did not work when they tried it in mice. It worked in humans by accident in Brussels and the humans were able to take advantage of it. Subzonal insertion of sperm (SUZI) was tried and the sperm was injected into the cytoplasm of the egg. However, all the other developments such as egg and embryo freezing, were started in mice and then moved to larger animals. If an embryonic stem cell line is developed from a female blastocyst, then we will only be able to generate X carrying sperm and not Y carrying sperm.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.